Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Increasing prescription of drugs for secondary prevention after myocardial infarction.

× No keyword cloud information.

4 in total

1. Use of secondary prophylaxis against myocardial infarction in the north of England.

Authors: M Eccles; C Bradshaw
Journal: BMJ Date: 1991-01-12

2. Cumulative meta-analysis of therapeutic trials for myocardial infarction.

Authors: J Lau; E M Antman; J Jimenez-Silva; B Kupelnick; F Mosteller; T C Chalmers
Journal: N Engl J Med Date: 1992-07-23 Impact factor: 91.245

3. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction.

Authors: D Ketley; K L Woods
Journal: Lancet Date: 1993-10-09 Impact factor: 79.321

4. Unsatisfactory management of patients with myocardial infarction admitted to general medical wards.

Authors: P J Lawson-Matthew; A T Wilson; P A Woodmansey; K S Channer
Journal: J R Coll Physicians Lond Date: 1994 Jan-Feb

4 in total

9 in total

1. The one-stop coronary cholesterol clinic: a multidisciplinary approach to implementing evidence-based treatment.

Authors: P D Giles; S Ramachandran; A J Whitaker; A W Phillips; S J Fell; A Mitchell; T D Coleman
Journal: Postgrad Med J Date: 1996-12 Impact factor: 2.401

Review 2. [Economic analysis of secondary prevention of coronary heart disease with simvastatin (Zocor) in Germany].

Authors: K Obermann; J M Schulenburg; G C Mautner
Journal: Med Klin (Munich) Date: 1997-11-15

3. Increasing prescription of drugs for secondary prevention of myocardial infarction. Authors' recommendations are too restrictive.

Authors: R J Sapsford; M B Robinson; A S Hall
Journal: BMJ Date: 1996-01-27

4. Increasing prescription of drugs for secondary prevention of myocardial infarction. Lipid lowering drugs should be considered too.

Authors: A Taylor; J P Reckless
Journal: BMJ Date: 1996-01-27

5. beta Blockade after myocardial infarction: systematic review and meta regression analysis.

Authors: N Freemantle; J Cleland; P Young; J Mason; J Harrison
Journal: BMJ Date: 1999-06-26

Review 6. Is aspirin underused in myocardial infarction?

Authors: J M Arnau; A Agustí
Journal: Pharmacoeconomics Date: 1997-11 Impact factor: 4.981

7. Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease.

Authors: J Bedson; T Whitehurst; M Lewis; P Croft
Journal: Br J Gen Pract Date: 2001-12 Impact factor: 5.386

8. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction.

Authors: Peter C Austin; Jack V Tu; Dennis T Ko; David A Alter
Journal: CMAJ Date: 2008-10-21 Impact factor: 8.262

9. Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management.

Authors: Pil Hyung Lee; Gyung-Min Park; Seungbong Han; Yong-Giun Kim; Jong-Young Lee; Jae-Hyung Roh; Jae-Hwan Lee; Young-Hak Kim; Seung-Whan Lee
Journal: Sci Rep Date: 2020-12-17 Impact factor: 4.379

9 in total